Related references
Note: Only part of the references are listed.Aspirin use for the primary prevention of coronary heart disease:: A population-based study in Switzerland
Nicolas Rodondi et al.
PREVENTIVE MEDICINE (2008)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Ian Graham et al.
EUROPEAN HEART JOURNAL (2007)
Competing events influence estimated survival probability - When is Kaplan-Meier analysis appropriate?
David Jean Biau et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2007)
Calibrating the SCORE cardiovascular risk chart for use in Spain
Susana Sans et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2007)
Actual and actuarial probabilities of competing risks: Apples and lemons
Gary L. Grunkemeier et al.
ANNALS OF THORACIC SURGERY (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up
Francisco Buitrago Ramirez et al.
MEDICINA CLINICA (2006)
Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001
I Hartz et al.
EUROPEAN HEART JOURNAL (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Trends in the leading causes of death in the United States, 1970-2002
A Jemal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The impact of coding process on observed cancer mortality trends in Switzerland
JM Lutz et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2004)
Cardiovascular risk of SCORE compared to Framingham.: Consequences of the change proposed by the European Societies
AM Galán et al.
MEDICINA CLINICA (2004)
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas
J Marrugat et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly
LMH Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world
F Levi et al.
HEART (2002)
Validation of the Omron HEM-907 device for blood pressure measurement
MA El Assaad et al.
BLOOD PRESSURE MONITORING (2002)
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
G Assmann et al.
CIRCULATION (2002)
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world
PCW van den Hoogen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
